Literature DB >> 9269635

Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).

J A Jefferson1, H H Lemmink, A E Hughes, C M Hill, H J Smeets, C C Doherty, A P Maxwell.   

Abstract

BACKGROUND: Alport syndrome is a hereditary nephritis that may lead to end-stage renal disease (ESRD) in young adult life and is often associated with sensorineural deafness and/or ocular abnormalities. The majority of families are X-linked due to mutations in the COL4A5 gene at Xq22. Autosomal forms of the disease are also recognized with recessive disease, having been shown to be due to mutations in the COL4A3 and COL4A4 genes on chromosome 2. Familial benign haematuria has also been mapped to this region in some families. SUBJECTS AND METHODS: We describe a large family with autosomal dominant Alport syndrome in which males and females are equally severely affected and one member with a mild sensorineural deafness reached ESRD aged 35 years. Renal biopsy in four affected patients demonstrated characteristic thickened and split glomerular basement membranes on electron-microscopy.
RESULTS: Genetic linkage analysis using markers on chromosome 2q demonstrated co-segregation of the disease with the markers D2S351 and D2S401 with a maximum lod score of 3.4 at zero recombination. Linkage to the COL4A4 gene was confirmed using an intragenic COL4A4 polymorphism. Mutation analysis has revealed a missense Leu36Pro mutation in exon 5 of the adjacent COL4A3 gene in the unaffected mother, which may lead to a more severe phenotype in affected family members carrying this mutation.
CONCLUSION: Mutations in the COL4A3 and COL4A4 genes can cause a spectrum of glomerular basement membrane disease ranging from autosomal recessive Alport syndrome to autosomal dominant Alport syndrome and familial benign haematuria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269635     DOI: 10.1093/ndt/12.8.1595

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  29 in total

1.  A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21.

Authors:  D H Cohn; T Shohat; M Yahav; T Ilan; G Rechavi; L King; M Shohat
Journal:  Am J Hum Genet       Date:  2000-08-04       Impact factor: 11.025

2.  Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.

Authors:  Kesha Rana; Stephen Tonna; Yan Yan Wang; Lydia Sin; Tina Lin; Elizabeth Shaw; Ishanee Mookerjee; Judy Savige
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

3.  Alport syndrome in a Kazakh family: a case study.

Authors:  Elena V Zholdybayeva; Saule E Rakhimova; Barshagul T Baikara; Nazym B Nigmatullina; Nagima M Mustapayeva; Kuvat T Momynaliev
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

4.  Autosomal Recessive Alport Syndrome Unveiled by Pregnancy.

Authors:  Erika R Drury; Isaac E Stillman; Martin R Pollak; Bradley M Denker
Journal:  Nephron       Date:  2019-08-13       Impact factor: 2.847

5.  A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.

Authors:  Asli Subasioglu Uzak; Bulent Tokgoz; Munis Dundar; Mustafa Tekin
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-08

6.  Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.

Authors:  A Toren; N Amariglio; G Rozenfeld-Granot; A J Simon; F Brok-Simoni; E Pras; G Rechavi
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

7.  Cyclosporine A treatment in patients with Alport syndrome: a single-center experience.

Authors:  Laura Massella; Andrea Onetti Muda; Antonia Legato; Giacomo Di Zazzo; Kostas Giannakakis; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2010-03-18       Impact factor: 3.714

8.  Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome.

Authors:  E Boye; G Mollet; L Forestier; L Cohen-Solal; L Heidet; P Cochat; J P Grünfeld; J B Palcoux; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

9.  Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.

Authors:  Laura Massella; Concetta Gangemi; Kostas Giannakakis; Antonella Crisafi; Tullio Faraggiana; Chiara Fallerini; Alessandra Renieri; Andrea Onetti Muda; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

Review 10.  The lens capsule.

Authors:  Brian P Danysh; Melinda K Duncan
Journal:  Exp Eye Res       Date:  2008-08-16       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.